PHARMACOKINETICS OF OXAPROZIN

被引:0
|
作者
MILLER, LG
机构
来源
CLINICAL PHARMACY | 1993年 / 12卷 / 04期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:256 / 256
页数:1
相关论文
共 50 条
  • [41] PIROXICAM AND OXAPROZIN - A CROSSOVER COMPARISON IN THE MANAGEMENT OF OSTEOARTHRITIS
    QUEIROS, MV
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1990, 47 (03): : 466 - 474
  • [42] Oxaprozin versus diclofenac in the treatment of rheumatoid arthritis
    Karbowski, A
    Schwitalle, M
    Eckardt, A
    AKTUELLE RHEUMATOLOGIE, 1998, 23 (01) : 11 - 15
  • [43] Influence of polymers on oxaprozin dissolution kinetics and mechanisms
    Zhang, Mingdong
    Fan, Weikang
    Ge, Kai
    Ji, Yuanhui
    CHEMICAL ENGINEERING RESEARCH & DESIGN, 2023, 200 : 803 - 811
  • [44] Validated HPLC Method for Analysis of Oxaprozin in a Formulation
    Ganesh, M.
    Thangabalan, B.
    Patil, R.
    Thakur, D.
    Kumar, A. Saravana
    Vinoba, M.
    Gangauly, S.
    Sivakumar, T.
    ACTA CHROMATOGRAPHICA, 2008, 20 (02) : 165 - 173
  • [45] Oxaprozin: kinetic and dynamic profile in the treatment of pain
    Kean, WF
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (08) : 1275 - 1277
  • [46] Case report: Oxaprozin and fatal toxic epidermal necrolysis
    Paul, CN
    Voigt, DW
    Clyne, KE
    Hansen, SL
    JOURNAL OF BURN CARE & REHABILITATION, 1998, 19 (04): : 321 - 323
  • [48] OXAPROZIN-INDUCED FULMINANT-HEPATITIS
    PURDUM, PP
    SHELDEN, SL
    BOYD, JW
    SHIFFMAN, ML
    ANNALS OF PHARMACOTHERAPY, 1994, 28 (10) : 1159 - 1161
  • [49] OXAPROZIN KINETICS IN WOMEN RECEIVING CONJUGATED ESTROGENS
    SCAVONE, JM
    GREENBLATT, DJ
    JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (09): : 725 - 725
  • [50] Toxic epidermal necrolysis following treatment with oxaprozin
    Carucci, JA
    Cohen, DE
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1999, 38 (03) : 233 - 234